A phase 1 trial of IMA203 shows promising activity in HLA-A*02+ patients with PRAME+ refractory solid tumors - Yan Leyfman, MD Cedrik M. Britten https://lnkd.in/dVA-pzC2 #OncoDaily #Oncology #Cancer #Health #Medicine #Sarcoma #Melanoma #RefractorySolidTumors #AutologousTCellTherapy
OncoDaily
Media Production
Boston, MA 41,993 followers
Your daily dose of hope, inspiration, and information in the fight against cancer.
About us
Cancer doesn't take a day off – neither do we. OncoDaily.com – your go-to destination for the latest news, insights, and patient stories from the world of oncology! We gather content from various sources, including posts from renowned oncologists on social media, news from oncology societies and cancer centers, patient and survivor stories, and career-related information for professionals. Our mission is to empower patients, survivors, and professionals with the knowledge and inspiration they need to fight cancer. By joining our community today, you can stay informed, inspired, and connected.
- Website
-
oncodaily.com
External link for OncoDaily
- Industry
- Media Production
- Company size
- 11-50 employees
- Headquarters
- Boston, MA
- Type
- Partnership
- Founded
- 2023
Locations
-
Primary
Get directions
Boston, MA, US
Employees at OncoDaily
-
Sami (Papacek) Mansfield
-
Neil Ranasinghe
Lead Technical Author
-
Gabrielle van Ramshorst
Consultant Surgical Oncologist Ghent University Hospital, Associate Editor Colorectal Disease
-
Samvel Chakhalyan
Co-founder Oncodaily / CTO, CDO P53 Inc. / COB at Technology Development Center Foundation / CEO at Clover Media Limited / Founder at b24.am…
Updates
-
Ira Mellman has joined PICI as President of Research Parker Institute for Cancer Immunotherapy https://lnkd.in/d7TdUbJv #OncoDaily #Oncology #Cancer #Health #Medicine #PICI
-
-
Myeloma Paper of the Day, April 11th, suggested by Robert Orlowski MD Anderson Cancer Center | Satabdi Saha | Krina Patel https://lnkd.in/d3XztQwh #OncoDaily #Oncology #Cancer #Health #Medicine #MM #MultipleMyeloma #IdecabtageneVicleucel
-
-
Advancing Care in Recurrent Low-Grade Serous Ovarian Cancer - Praveen Kumar Marimuthu https://lnkd.in/dStk-YX2 #Cancer #CancerResearch #OvarianCancer #Medicine #Health #Oncology #OncoDaily
-
-
The Max Foundation – Sweta Agrawal received the Excellence in Patient Advocacy Award https://lnkd.in/d2c74Yhx #OncoDaily #Oncology #Cancer #Health #Medicine #TheMaxFoundation
-
-
What happens after patients stop taking GLP-1 receptor agonists - Yan Leyfman, MD https://lnkd.in/d-ug47c9 Eric Nemec Sara Berg Hannah Lillicraf Suzanne Rose, MS, PhD, CCRC, FACRP #Cancer #CancerResearch #GLP1RA #WeightLossResearch #Medicine #Health #ObesityMedicine #Oncology #OncoDaily
-
-
Tirzah Petta has been appointed as Director of the USC NCCC Molecular Genomics Core Caryn Lerman Ph.D. https://lnkd.in/dwev6seg #Cancer #Medicine #Health #Healthcare #Oncology #OncoDaily
-
-
Abstract Submission is open for AORTIC- Africa 2025 https://lnkd.in/dRBe-ceb #OncoDaily #Oncology #Cancer #Health #Medicine #AORTIC2025 #AORTICAfrica
-
-
Beating Durvalumab Monotherapy Post-CRT in Unresectable Stage III NSCLC - David Planchard https://lnkd.in/dj5_fi5f #Cancer #CancerResearch #ISCO25 #LungCancer #NSCLC #CancerTreatment #Medicine #Health #Oncology #OncoDaily
-
-
Understanding the Clinical Implications of HER2-Low – A Quick and Accessible Read - Sofia Menshikova https://lnkd.in/g-E596B6 #Cancer #OncoDaily #Medicine #Oncology
-